| Literature DB >> 29495627 |
Igor Khlusov1,2, Larisa Litvinova3, Valeria Shupletsova4, Olga Khaziakhmatova5, Elena Melashchenko6, Kristina Yurova7, Vladimir Leitsin8, Marina Khlusova9, Vladimir Pichugin10, Yurii Sharkeev11,12.
Abstract
The response of the human Jurkat T cell leukemia-derived cell line (Jurkat T cells) after 24 h of in vitro exposure to a titanium substrate (12 × 12 × 1 mm³) with a bilateral rough (Ra = 2.2-3.7 μm) titanium oxide coating (rTOC) applied using the micro-arc method in a 20% orthophosphoric acid solution was studied. A 1.5-fold down-regulation of hTERT mRNA expression and decreases in CD3, CD4, CD8, and CD95 presentation and IL-4 and TNFα secretion were observed. Jurkat T cell inactivation was not correlated with the generation of intracellular reactive oxygen species (ROS) and was not mediated by TiO₂ nanoparticles with a diameter of 14 ± 8 nm at doses of 1 mg/L or 10 mg/L. The inhibitory effect of the rTOC (Ra = 2.2-3.7 μm) on the survival of Jurkat T cells (Spearman's coefficient rs = -0.95; n = 9; p < 0.0001) was demonstrated by an increase in the necrotic cell count among the cell population. In turn, an elevation of the Ra index of the rTOC was accompanied by a linear increase (r = 0.6; p < 0.000001, n = 60) in the magnitude of the negative electrostatic potential of the titanium oxide surface. Thus, the roughness of the rTOC induces an electrostatic potential and decreases the viability of the immortalized Jurkat T cells through mechanisms unrelated to ROS generation. This may be useful for replacement surgery applications of rough TiO₂ implants in cancer patients.Entities:
Keywords: TiO2 nanoparticles; in vitro; reactive oxygen species; surface electrostatic potential; titanium substrate; tumor cell death
Year: 2018 PMID: 29495627 PMCID: PMC5872939 DOI: 10.3390/ma11030360
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Figure 1SEM-images of the titanium oxides (TiO2) coating before sandblasting and subsequent acid etching (a), the Ti surface after acid etching (b), EDX spectrum (c) and X-ray diffraction pattern of the TiO2 coating (d).
Sequences and probes used for polymerase chain reaction (PCR) to measure hTERT expression in Jurkat T cells.
| Gene | Primers and Probes | Amplicon Mass |
|---|---|---|
| Forward: 5′-ACCGTCTGCGTGAGGAGATC-3′ | 131 base pairs | |
| 18S rRNA | Forward: 5′-CTGAGAAACGGCTACCACATC-3′ | 153 base pairs |
Figure 2Algorithm for determining intracellular levels of ROS after 24 h in culture with the addition of a nanoparticle suspension. (a) Jurkat gating based on a forward scatter (FSC) vs. side scatter (SSC) plot; (b) The analysis was carried out using gating of Jurkat cells. The abscissa axis is the fluorescence intensity of antibodies against Viability Fixable Dye; the ordinate is the number of cells; (c) Evaluation of the production of reactive oxygen species.
Figure 3Gating strategy for Jurkat T cell CD staining. (a) Jurkat cell gating based on a forward scatter (FSC) vs. side scatter (SSC) plot; (b) The analysis was carried out using gating of Jurkat cells. The abscissa axis is the fluorescence intensity of the antibodies against Annexin; the ordinate is the fluorescence intensity of the antibodies against propidium iodide. Area “III” contains viable cells; (c) The analysis was carried out using gating on the “III” area. Histogram of the distribution of Jurkat cells; the axis of abscissas is the fluorescence intensity of the antibodies against CD3; the ordinate is the number of cells; (d1) The analysis was carried out using gating of the “III” area. Histogram of the distribution of Jurkat cells; the abscissa axis is the fluorescence intensity of the antibodies against CD56; the ordinate axis is the fluorescence intensity of the antibodies against CD16, (d2–d8) The analysis was carried out using gating of the "III" area. Histogram of the distribution of Jurkat cells; the abscissa axis is the fluorescence intensity of the antibodies against CD3; the ordinate axis is the fluorescence intensity of the antibodies against CD25, CD95, CD71, CD8, CD4, CD45RA, or CD45RO.
Monoclonal antibody panel used for Jurkat T cell analysis.
| Studied Subpopulation | Fluorochromes and Labeled Monoclonal Antibodies | ||||
|---|---|---|---|---|---|
| PE | FITC | VioBlue | PE | APC | |
| Jurkat T cells | Propidium iodide | Annexin V | CD3 | CD56 | CD16 |
| CD4 | CD8 | ||||
| CD71 | CD95 | ||||
| CD45RA | CD45RO | ||||
| - | CD25 | ||||
Figure 4Regression of Jurkat T cell viability after 24 h of culture in the presence of rough TiO2-coated titanium samples.
hTERT expression levels in Jurkat T cells after 24 h of culture in the presence of a model matrix consisting of a TiO2 coating on a titanium substrate, Me (Q1–Q3).
| Group Studied ( | |
|---|---|
| Control cell culture | 9.81 (8.90–11.18) |
| Cell culture in contact with the TiO2-coated titanium samples | 6.00 (4.48–6.95) * |
Note: Here and below, n = the number of observations (samples) in each group; * = statistical significance (p < 0.05) in comparison with the control according to the Mann-Whitney U-test; a.u. = arbitrary units.
Membrane molecular markers and death indices of Jurkat T cells after 24 h of culture in the presence of the TiO2 coating Me (Q1–Q3).
| Dead or Necrotic Cells, % | Cells Expressing Specific Surface Markers, % | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apoptosis | Necrosis | CD3 | CD4 | CD8 | CD71 | CD45RO | CD45RA | CD16 | CD56 | CD25 | CD95 |
| Cells cultured on plastic surface (control), | |||||||||||
| 5.2 | 8.2 | 98 | 27.5 | 2.16 | 94.0 | 0.55 | 94.9 | 2.46 | 2.5 | 0 | 1.0 |
| Cells in contact with the TiO2-coated titanium samples, | |||||||||||
| 5.9 | 15.3 | 97.5 | 25.4 | 0.31 | 94.1 | 0.50 | 94.0 | 2.33 | 2.36 | 0 | 0.56 |
* = statistical significance (p < 0.05) in comparison with the control according to the Mann-Whitney U-test.
Cytokine concentrations (pg/mL) in the supernatants of Jurkat T cells after 24 h of culture in the presence of a TiO2 coating, Me (Q1–Q3).
| Cytokine Concentration | ||||||
|---|---|---|---|---|---|---|
| IL-1b | IL-2 | IL-4 | IL-6 | IL-8 | IL-10 | TNFα |
| Control cell culture on plastic surface, | ||||||
| 0 | 5.67 | 1.10 | 0 | 11.12 | 6.10 | 14.95 |
| Cell culture in contact with the TiO2-coated titanium samples, | ||||||
| 0 | 6.10 | 0 (0–0.79) * | 0 | 12.78 | 7.80 | 13.48 |
* = statistical significance (p < 0.05) in comparison with the control according to the Mann-Whitney U-test.
Figure 5Location of Jurkat T cells on the rough surface of the TiO2 coating. Reflecting optical microscopy, dark field. Magnification, 1000×.
Spearman’s correlation coefficient between the R of the TiO2 coating and the morphofunctional parameters of the Jurkat T cell cultures.
| Index | % Viable Cells | % Apoptotic Cells | % Necrotic Cells | CD8 | CD56 | IL-2 | IL-4 | IL-10 | TNFa |
|---|---|---|---|---|---|---|---|---|---|
| −0.95 | −0.69 | 0.95 | 0.71 | −0.95 | −0.95 | −0.69 | −0.92 | 0.68 |
Proportions of apoptotic Jurkat T cells and intracellular levels of ROS after 24 h of culture with nanoparticle suspensions, Me (Q1–Q3).
| No. | Group | Results | |
|---|---|---|---|
| Number of Apoptotic Cells, % | ROS, a.u. | ||
| 1 | Cells cultured on plastic surface without nanoparticle suspension, | 5.87 | 0.130 |
| Concentration of TiO2 nanoparticle samples, | |||
| 2 | 100 MACs | 4.82 | 0.131 |
| 3 | 10 MACs | 4.76 | 0.139 |
| Concentration of Fe3O4 nanoparticle samples, | |||
| 4 | 10 MACs | 4.39 | 0.123 |
Note: MACs = maximum allowable concentrations; a.u. = arbitrary units; P1 significant difference compared with the corresponding group according to the Mann-Whitney U-test.
Cytokine levels (pg/mL) in the culture medium after 24 h of culture of Jurkat T cells with nanoparticle suspensions, Me (Q1–Q3).
| No | Group | Cytokine Concentration | ||
|---|---|---|---|---|
| TNFα | IL-2 | IL-4 | ||
| 1 | Cells cultured on plastic surface without nanoparticle samples, | 27.41 | 4.02 | 4.14 |
| Concentration of TiO2 nanoparticle samples, | ||||
| 2 | 100 MACs | 33.52 | 4.73 | 3.67 |
| 3 | 10 MACs | 33.51 | 3.61 | 3.40 |
| Concentration of Fe3O4 nanoparticle samples, | ||||
| 4 | 10 MACs | 26.62 | 4.23 | 4.39 |
Note: P1, P4 = statistically significant differences compared with the corresponding group according to the Mann-Whitney U-test.